• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE GENUS; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE GENUS; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-1416
Device Problems Premature Discharge of Battery (1057); Unexpected Therapeutic Results (1631); Battery Problem (2885)
Patient Problems Movement Disorder (4412); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/01/2023
Event Type  malfunction  
Event Description
It was reported that the deep brain stimulation (dbs) patient experienced early depletion of the implantable pulse generator (ipg).The patient underwent a revision procedure where the ipg was replaced.The patient was doing well post-operatively.
 
Manufacturer Narrative
Engineers inspected and analyzed the returned device.The ipg was confirmed to have reached end of service eos state.The device was in service for a total of 4 months and 12 days with an average energy use index eui of 93.7 which confirmed high energy consumption use.The device longevity was within the expected range based on the eui measurement.Premature battery depletion was not confirmed.The device exhibited normal characteristics.A product labeling review identified that the device was used per the instructions for use ifu product label.Additionally, it states, when the stimulator battery is fully depleted, the end of service eos indicator will be displayed on the remote control and clinician programmer.Stimulation will not be available.Surgery is required to replace the implanted non rechargeable stimulator to continue providing stimulation.The longevity of the non rechargeable stimulator battery depends on the following factors, programmed parameters, system impedance, hours per day of stimulation, changes to stimulation made by the patient.Dystonia may be triggered by the loss of dbs therapy as well as by other factors and may lead to respiratory distress or failure, rhabdomyolysis, multiorgan failure, and death.Ensure that patients and caregivers understand the importance of maintaining dbs therapy and that its loss for any reason, accidental turnoff, battery depletion, and system failure could cause symptom return and are a known risks with the use of deep brain stimulation.
 
Event Description
It was reported that the deep brain stimulation (dbs) patient experienced early depletion of the implantable pulse generator (ipg).The patient underwent a revision procedure where the ipg was replaced.The patient was doing well post-operatively.Additional information was received indicating the patients dystonia symptoms returned due to the depletion of the ipg causing a loss of stimulation.
 
Event Description
It was reported that the deep brain stimulation (dbs) patient experienced early depletion of the implantable pulse generator (ipg).The patient underwent a revision procedure where the ipg was replaced.The patient was doing well post-operatively.Additional information was received indicating the symptoms the patient experienced due to the depletion of the ipg was dystonia.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE GENUS
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
erik sherburne
25155 rye canyon loop
valencia, CA 91355
7632920920
MDR Report Key17782259
MDR Text Key323851034
Report Number3006630150-2023-05709
Device Sequence Number1
Product Code NHL
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberDB-1416
Device Catalogue NumberDB-1416
Device Lot Number214960
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/07/2023
Initial Date FDA Received09/20/2023
Supplement Dates Manufacturer Received10/08/2023
11/06/2023
Supplement Dates FDA Received11/01/2023
12/05/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/22/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-